Literature DB >> 19636535

Role of sphingosine-1-phosphate (S1P) and the S1P(2) receptor in allergen-induced, mast cell-dependent contraction of rat lung parenchymal strips.

A Trifilieff1, F Baur, J R Fozard.   

Abstract

Lung parenchymal strips isolated from ovalbumin-sensitized rats manifest a mast cell-dependent, biphasic contraction when challenged with allergen. The first phase is mediated by the release of preformed 5-HT while the second phase is dependent on de novo synthesis of leukotrienes. Sphingosine 1-phosphate (S1P) is a sphingolipid metabolite which is readily generated in mast cells and has been demonstrated to be an important regulator of allergen-induced mast cell activation. We have used the parenchymal strip to explore the role of sphingosine 1-phosphate and the S1P(2) receptor in the two components of the acute response to allergen. Lung parenchymal strips were prepared from Brown Norway rats actively sensitized to ovalbumin. The strips were set up in organ baths and contractile responses measured isometrically. The inhibitors of sphingosine kinase, D-erythro-NN-dimethylsphingosine (dimethylsphingosine) and 4-[4-(4-chloro-phenyl)-thiazol-2-ylamino]-phenol (SKI-II) inhibited concentration-dependently both phases of the contractile response induced by 0.1 microg ml(-1) ovalbumin. The effects were seen at concentrations similar to those which inhibit the purified enzyme and were selective in that neither the contractile response to adenosine nor that to 5-hydroxytryptamine was affected. JTE-013 (a selective S1P(2) receptor antagonist) also blocked the response to ovalbumin (0.1 microg ml(-1)). However, the concentrations of JTE-013 required (microM) were substantially higher than its affinity for the S1P(2) receptors (nM). However, when tested against a lower concentration of ovalbumin (0.03 microg ml(-1)), JTE-013 inhibited the response with nM potency. These data demonstrate the importance of S1P and the S1P(2) receptor as regulators of allergen-induced activation of mast cells in their natural environment in the rat lung.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19636535     DOI: 10.1007/s00210-009-0438-4

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

1.  Antitumor activity of sphingosine kinase inhibitors.

Authors:  Kevin J French; John J Upson; Staci N Keller; Yan Zhuang; Jong K Yun; Charles D Smith
Journal:  J Pharmacol Exp Ther       Date:  2006-04-21       Impact factor: 4.030

Review 2.  The role of the mast cell in the pathophysiology of asthma.

Authors:  Peter Bradding; Andrew F Walls; Stephen T Holgate
Journal:  J Allergy Clin Immunol       Date:  2006-04-27       Impact factor: 10.793

Review 3.  Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network.

Authors:  Hugh Rosen; Edward J Goetzl
Journal:  Nat Rev Immunol       Date:  2005-07       Impact factor: 53.106

4.  The receptor mechanism mediating the contractile response to adenosine on lung parenchymal strips from actively sensitised, allergen-challenged Brown Norway rats.

Authors:  Cedric Wolber; John R Fozard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-01-27       Impact factor: 3.000

5.  Mechanism of airway hyperresponsiveness to adenosine induced by allergen challenge in actively sensitized Brown Norway rats.

Authors:  J P Hannon; B Tigani; I Williams; L Mazzoni; J R Fozard
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

6.  IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses.

Authors:  Ana Olivera; Nicole Urtz; Kiyomi Mizugishi; Yumi Yamashita; Alasdair M Gilfillan; Yasuko Furumoto; Haihua Gu; Richard L Proia; Thomas Baumruker; Juan Rivera
Journal:  J Biol Chem       Date:  2005-11-29       Impact factor: 5.157

7.  Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist.

Authors:  Makoto Osada; Yutaka Yatomi; Tsukasa Ohmori; Hitoshi Ikeda; Yukio Ozaki
Journal:  Biochem Biophys Res Commun       Date:  2002-12-06       Impact factor: 3.575

Review 8.  Autocrine and paracrine roles of sphingosine-1-phosphate.

Authors:  Sergio E Alvarez; Sheldon Milstien; Sarah Spiegel
Journal:  Trends Endocrinol Metab       Date:  2007-09-29       Impact factor: 12.015

9.  Discovery and evaluation of inhibitors of human sphingosine kinase.

Authors:  Kevin J French; Randy S Schrecengost; Brian D Lee; Yan Zhuang; Staci N Smith; Justin L Eberly; Jong K Yun; Charles D Smith
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

10.  Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis.

Authors:  Puneet S Jolly; Meryem Bektas; Ana Olivera; Claudia Gonzalez-Espinosa; Richard L Proia; Juan Rivera; Sheldon Milstien; Sarah Spiegel
Journal:  J Exp Med       Date:  2004-04-05       Impact factor: 14.307

View more
  9 in total

1.  Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.

Authors:  Zhenping Wang; Yuping Lai; Jamie J Bernard; Daniel T Macleod; Anna L Cogen; Bernard Moss; Anna Di Nardo
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

2.  Sphingosine-1-phosphate acting via the S1P₁ receptor is a downstream signaling pathway in ceramide-induced hyperalgesia.

Authors:  Tim Doyle; Zhoumou Chen; Lina M Obeid; Daniela Salvemini
Journal:  Neurosci Lett       Date:  2011-05-13       Impact factor: 3.046

3.  Population of sensory neurons essential for asthmatic hyperreactivity of inflamed airways.

Authors:  Dimitri Tränkner; Nadeau Hahne; Ken Sugino; Mark A Hoon; Charles Zuker
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

4.  Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer.

Authors:  James W Antoon; William D Meacham; Melyssa R Bratton; Evelyn M Slaughter; Lyndsay V Rhodes; Hasina B Ashe; Thomas E Wiese; Matthew E Burow; Barbara S Beckman
Journal:  J Mol Endocrinol       Date:  2011-04-28       Impact factor: 5.098

Review 5.  Regulation of mast cell responses in health and disease.

Authors:  Alasdair M Gilfillan; Michael A Beaven
Journal:  Crit Rev Immunol       Date:  2011       Impact factor: 2.214

6.  Gene miles-apart is required for formation of otic vesicle and hair cells in zebrafish.

Authors:  Z-y Hu; Q-y Zhang; W Qin; J-w Tong; Q Zhao; Y Han; J Meng; J-p Zhang
Journal:  Cell Death Dis       Date:  2013-10-31       Impact factor: 8.469

Review 7.  Sphingosine 1-Phosphate Receptor Modulators and Drug Discovery.

Authors:  Soo-Jin Park; Dong-Soon Im
Journal:  Biomol Ther (Seoul)       Date:  2017-01-01       Impact factor: 4.634

8.  Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism.

Authors:  Amanda Finley; Zhoumou Chen; Emanuela Esposito; Salvatore Cuzzocrea; Roger Sabbadini; Daniela Salvemini
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

Review 9.  Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks.

Authors:  Kira V Blankenbach; Stephanie Schwalm; Josef Pfeilschifter; Dagmar Meyer Zu Heringdorf
Journal:  Front Pharmacol       Date:  2016-06-21       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.